Autoimmunerkrankungen und Allergien

Wilfried Bieger

doi:10.1055/s-0033-1360103

Zeitschrift für Orthomolekulare Medizin, Inhaltsverzeichnis

Zeitschrift für Orthomolekulare Medizin 2013; 11(4): 15-19
DOI: 10.1055/s-0033-1360103

Praxistipps

Hippokrates Verlag in MVS Medizinverlage Stuttgart GmbH & Co. KG Stuttgart · New York

Autoimmunerkrankungen und Allergien

Risikofaktoren, Diagnostik und orthomolekulare Therapie

Wilfried Bieger

Abstract

Zusammenfassung

Bei der Entstehung von Autoimmunität und Allergien sind v. a. genetisch disponierende Faktoren sowie Infektionen von Bedeutung. Die Diagnostik erfolgt über die Bestimmung der im Blut zirkulierenden T-Zellen und der spezifischen Zytokine. Für die orthomolekulare Therapie steht eine Reihe von Wirkstoffen mit unterschiedlichen immunologischen Effekten zur Verfügung.

Schlüsselwörter

Autoimmunerkrankungen - HLA-Muster - Risikofaktoren - Infektionskrankheiten - Allergien - Diagnostik - T-Zell-Aktivitätsprofil - Zytokinmatrix - orthomolekulare Therapie

Volltext

Referenzen

Literatur
1 Bonilla FA, Oettgen HC. Adaptive Immunity. J Allergy Clin Immunol 2010; 125: S3-40
2 Frauwirth KA, Thompson CB. Activation and inhibition of lymphocytes by costimulation. J Clin Invest 2002; 109: 295-299
3 Wherry EJ. T cell exhaustion. Nature Immunol 2011; 12: 492-499
4 Bovman O. Bystander activation of CD4+ T cells. Eur J Immunol 2010; 40: 936-939
5 Chu T, Tyznik AJ, Roepke S et al. Bystander-activated memory CD8 T cells control early pathogen load in an innate-like, NKG2D-dependent manner. Cell Reports 2013; 3 (3) 701-708
6 Mosmann TR, Cherwinski H, Bond MW et al. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986; 136: 2348-2357
7 Schreiber S, Rosenstiel P, Albrecht M et al. Genetics of Crohn disease, an archetypal inflammatory barrier disease. Nat Rev Genet 2005; 6: 376-388
8 Bettelli E, Korn T, Oukka M et al. Induction and effector functions of Th17 cells. Nature 2008; 453: 1051-1057
9 Sakaguchi S, Sakaguchi N, Asano M et al. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995; 155: 1151-1164
10 OʼShea JJ, Paul WE. Mechanisms Underlying Lineage Commitment and Plasticity of Helper CD4+ T Cells. Science 2010; 327: 1098-1102
11 Zandmann-Goddard G, Peeva E, Shoenfeld Y. Gender and autoimmunity. Autoimmun Rev 2007; 6: 366-372
12 Gregersen PK, Behrens TW. Genetics of autoimmune diseases – disorders of immune homeostasis. Nature Rev Genetics 2006; 7: 917-928
13 Pierdomeninici M, Ortona E. Estrogen Impact on Autoimmunity Onset and Progression: the Paradigm of Systemic Lupus Erythematosus. Int Trends Immunity 2013; 1: 24-34
14 Cutolo M, Straub RH. Insights into endocrine-immunological disturbances in autoimmunity and their impact on treatment. Arthr Res Ther 2009; 11: 218-226
15 Yang CY, Leung PSC, Adamopoulos E, Gershwin ME. The Implication of Vitamin D and Autoimmunity: a Comprehensive Review. Clin Rev Allerg Immunol 2013; 45: 217-226
16 Niller HH, Wolf H, Minarovits J. Regulation and dysregulation of Epstein-Barr virus latency: Implications for the development of autoimmune diseases. Autoimmunity 2008; 41: 298-328
17 Grammatikos AP. The genetic and environmental basis of atopic diseases. Ann Med 2008; 40: 482-495
18 Frischmeyer-Guerrerio PA, Guerrerio AL, Oswald G et al. TGFβ Receptor Mutations Impose a Strong Predisposition for Human Allergic Disease. Sci Transl Med 2013; 5 (195) 195ra94
19 Bach JF. The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med 2002; 347: 911-920
20 Kamradt T, Gögger R, Erb KJ. Induction, exacerbation and inhibition of allergic and autoimmune diseases by infection. Trends Immunol 2005; 26: 260-267
21 Minang J, Areström I, Ahlborg N. ELISpot Displays a Better Detection over ELISA of T Helper (Th) 2-Type Cytokine-Production by Ex Vivo-Stimulated Antigen-Specific T Cells from Human Peripheral Blood. Immunol Invest 2008; 37: 279-291
22 Wang J, Su B, Ding Z et al. Cimetidine enhances immune response of HBV DNA vaccination via impairment of the regulatory function of regulatory T cells. Biochem Biophys Res Comm 2008; 372: 491-496
23 Chauhan VP, Martin JD, Liu H et al. Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels. Nat Commun 2013; 4: 2516
24 Pludowski P, Holick MF, Pilz S. Vitamin D effects on musculoskeletal health, immunity, autoimmunity, cardiovascular disease, cancer, fertility, pregnancy, dementia and mortality – A review of recent evidence. Autoimm Rev 2013; 12: 976-989
25 Jiang S, Dong C. A complex issue on CD4⁺ T-cell Subsets. Immunol Rev 2013; 252: 5-11
26 Kabelitz D, Schreiber S. Autoimmunität Physiologische Kontrollmechanismen und Wege zur Autoimmunerkrankung. Internist 2009; 50: 267-275
27 MacLeod KL, Kappler JW, Marrack P. Memory CD4 T cells: generation, reactivation and re-assignment. Immunology 2010; 130: 10-15
28 Perricone C, De Carolis C, Perricone R. Glutathione: A key player in autoimmunity. Autoimmunity Rev 2009; 8: 697-701
29 Schiraldi M, Moestier M. Autoimmunity and the environment: How can a chemical element elicit complex immunopathology? Lessons from mercury-induced autoimmunity. Trends Immunol 2009; 30: 502-509